Delaware court rules on claim construction in Banzel patent row


A US district court yesterday (March 17) gave its opinion on how a group of disputed patent claims must be construed in a patent infringement case between Eisai and Novartis and several generic drug makers.

Eisai, Novartis, Glenmark, claim construction, patent infringement, patent